Why the study?
Male infertility is a rapidly growing global problem, and analyzing changes in seminal plasma clusterin glycosylation may shed light on fertilization mechanisms and serve as an additional diagnostic marker.
Can the glycosylation analysis of seminal plasma clusterin serve as a diagnostic marker for male infertility?
Can the glycosylation analysis of seminal plasma clusterin serve as a diagnostic marker for male infertility?
Analysis of seminal plasma clusterin glycosylation may provide new insights into fertilization mechanisms and serve as a novel biomarker for male infertility.
Answers are grounded in this paper and cite their sources.
May support seminal clusterin glycosylation as a male infertility biomarker; leaves open prospective validation before clinical adoption.
Male infertility is becoming a rapidly growing problem around the world, mainly in the highly developed countries. Seminal proteome composition seems to be one of the crucial factors of the proper course of fertilization - clusterin (CLU) is among the most important ones. CLU, as one of the crucial seminal plasma glycoproteins, plays a very important role in sperm capacitation and immune tolerance in the female reproductive tract. CLU is also known as a sensitive marker of oxidative stress. It has six n-glycosylation sites and also exhibits chaperone activity. An analysis of changes in the profile and degree of CLU glycosylation may shed some new light on the molecular mechanisms of the fertilization process and may be used as an additional diagnostic marker of male fertility. This study constitutes a review of the recently available literature concerning human seminal CLU, including changes in its glycosylation, analyzed in the context of human reproduction.
No takes yet. Share an insight, caveat, or question.
Janiszewska et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: